id,answer
1702,[CLS]
3135,[CLS]
650,[CLS]
741,[CLS]
2949,[CLS]
316,[CLS]
4610,modulates transcript stability and translation in eukaryotic cells
386,[CLS]
3196,self - contained vesicles
2578,Actoxumab and bezlotoxumab
3851,[CLS]
1119,AAUAAA
2179,Strokes are typically ischemic
885,[CLS]
2652,[CLS]
846,Bioprinting has no or little side effect to the printed mammalian cells
3099,[CLS]
2164,[CLS]
2461,[CLS]
75,[CLS]
1355,selectively mimicking hypothyroidism
1532,[CLS]
4021,Zostavax
1993,a key step in lipid biosynthesis
3759,[CLS]
3503,[CLS]
2181,[CLS]
1942,[CLS]
1259,hydrolysis of 8 - oxodGTP
2931,[CLS]
1056,Sequence - specific nucleases such as TALEN and the CRISPR / Cas9 system
3043,Bcr - Abl tyrosine kinase
1282,[CLS]
169,lack of an antidote
2143,overactive bladder
2246,[CLS]
3088,Eliquis
2399,"growth failure and weight gain, facial fullness, blood pressure, bone health, cataracts, gastrointestinal symptoms, behavior, hypertrichosis, and need for medication interventions"
30,[CLS]
2495,[CLS]
2716,anticoagulant therapy
1715,"mental status changes, oculomotor dysfunction and ataxia"
198,6
3821,TAL1 / SCL
1200,GC box
1106,"FOLFOX [ infusional fluorouracil, leucovorin, and oxaliplatin"
4289,[CLS]
1432,[CLS]
3913,[CLS]
851,"inhibition of renin ' s catalytic activity, the most proximal and rate - limiting step in renin - angiotensin system activation"
1939,[CLS]
531,[CLS]
1300,[CLS]
4129,CYP2C19 * 2
3720,[CLS]
1812,[CLS]
3883,[CLS]
2678,Single - cell sequencing assay for transposase - accessible chromatin
286,[CLS]
2503,open chromatin profiling
4578,[CLS]
1966,[CLS]
3185,cat flea
593,[CLS]
1172,X
1231,[CLS]
3614,[CLS]
1338,[CLS]
1716,[CLS]
1596,[CLS]
197,transcribed
2337,[CLS]
2099,[CLS]
1950,unknown
979,an orally bioavailable derivative
629,[CLS]
1619,did not
3228,[CLS]
1110,double - vertical
337,quality - control ( QC ) autophagy
2175,[CLS]
3114,[CLS]
2750,Haemophysalis longicornis ticks
244,[CLS]
2208,[CLS]
1330,the mechanisms facilitating cellular repositioning and redeployment during embryonic development and tissue reconstruction after injury
2691,"milk, blood and urine"
1794,[CLS]
3623,[CLS]
2419,[CLS]
1975,X
1834,epithelial cells
3004,[CLS]
4573,feeding
3788,[CLS]
2071,[CLS]
3409,"human and mouse urine, cell culture medium from mouse proximal tubular cells, and mouse plasma"
854,[CLS]
2631,Environmental factors
1995,high levels of histone H3 lysine 27 acetylation ( H3K27ac ) and strong depletion of H3K27 trimethylation ( H3K27me3 )
6,[CLS]
25,junctin
4022,common ancestor
2894,an iron - dependent form of regulated nonapoptotic cell death
834,[CLS]
294,substantial degree of specificity for particular components of bacterial membranes
2125,[CLS]
1240,bidirectional or polymorphic ventricular arrhythmias
2829,ethinylestradiol and levonorgestrel
1795,an R package that implements a permutation test framework specifically designed to work with genomic regions
2110,interleukin 4 and interleukin 13
2027,[CLS]
3280,[CLS]
342,aortic root dilatation and aortic valve regurgitation
1956,DAL cluster
3762,treatment of different human inflammatory diseases
3820,[CLS]
3117,several software tools
3364,[CLS]
1856,[CLS]
32,[CLS]
4265,[CLS]
2023,[CLS]
24,[CLS]
3903,"hydrometrocolpos, polydactyly, and congenital heart defects"
1143,Boolean analysis
3284,[CLS]
4656,[CLS]
947,NOTCH3
3697,[CLS]
433,"recurrent facial palsy, lingua plicata, and facial edema"
4494,[CLS]
3379,failed to meet the primary endpoint in two large phase III studies
742,[CLS]
2272,[CLS]
4027,"[CLS] Explain the use of Radio Frequency Ablation as a treatment [SEP] Radiofrequency ablation ( RFA ) is an important standard therapy for cardiac arrhythmias, but direct monitoring of tissue treatment is currently lacking. We demonstrate an RFA catheter integrated with polarization sensitive optical coherence tomography ( PSOCT ) for directly monitoring the RFA process in real time. The integrated RFA / OCT catheter was modified from a standard clinical RFA catheter and includes a miniature forward - viewing cone - scanning OCT probe. The PSOCT system was validated with a quarter - wave plate while the RFA function of the integrated catheter was validated by comparing lesion sizes with those made with an unmodified RFA catheter. Additionally, the integrated catheter guided catheter - tissue apposition and monitored RFA lesion formation in cardiac tissue in real time. The results show that catheter - tissue contact can be characterized by observing the features of the blood and tissue in the acquired OCT images and that RFA lesion formation can be confirmed by monitoring the change in phase retardance in the acquired PSOCT images. This system demonstrates the feasibility of an integrated RFA / OCT catheter to deliver RF energy and image the cardiac wall simultaneously and justifies further research into use of this technology to aid RFA therapy for cardiac arrhythmias"
1511,cell - surface proteins
4257,folding of proteins
3140,[CLS]
3840,[CLS]
3565,[CLS]
4173,infiltration of the leptomeninges by tumor cells
688,[CLS]
1710,unenhanced ( three - dimensional constructive interference in steady state ( 3D - CISS ) ) and contrast - enhanced MR cisternography
1354,poorly understood
810,[CLS]
4486,[CLS]
8,[CLS]
4253,[CLS]
1237,large numbers of living animals can easily be screened
3301,[CLS]
4326,[CLS]
1109,exocrine glands
4250,[CLS]
2663,[CLS]
3573,rare subcutaneous arteriovenous fistulae affecting the scalp
3242,"hereditary nephritis, sensorineural deafness, and ocular abnormalities"
2627,[CLS]
4570,[CLS]
2722,[CLS]
1281,[CLS]
3447,[CLS]
1876,1980
4301,[CLS]
1906,biodiversity
3132,accurately predicts MoRFs in protein sequences
4054,[CLS]
3706,the transgene was highly expressed upon both maternal and paternal inheritance
3267,[CLS]
2162,X - linked dominant disorder
3057,[CLS]
1195,[CLS]
3786,[CLS]
2230,[CLS]
2745,[CLS]
2330,DNA methylation is associated with increasing nucleosome occupancy
138,"TaMET1, TaMET2a, TaMET2b, TaCMT, TaMET3, respectively. BLASTX searches and phylogenetic analysis suggested that five cDNAs belonged to four classes ( Dnmt1, Dnmt2, CMT and Dnmt3"
3340,[CLS]
4323,[CLS]
1194,[CLS]
3517,MBF and SBF
1625,[CLS]
1620,four
3247,Rett syndrome
2624,[CLS]
1962,[CLS]
803,[CLS]
4278,[CLS]
2601,"an abrupt emotional "" drop"
667,[CLS]
2605,[CLS]
3338,[CLS]
3609,chronic myeloid leukemia and Ph + acute lymphoblastic leukemia
1302,unclear
11,I - IV
1201,[CLS]
1034,[CLS]
3858,DeepTRIAGE ( Deep learning for the TRactable Individualised Analysis of Gene Expression
1452,[CLS]
2409,[CLS]
3576,[CLS]
3093,oral alternative
4713,[CLS]
3630,"anti - dsDNA titre, C3 and C4 levels"
1929,[CLS]
3886,[CLS]
1560,[CLS]
1443,localized skin reactions
1203,[CLS]
847,High levels of transcription
4417,[CLS]
4347,[CLS]
3256,[CLS]
4548,[CLS]
1556,[CLS]
1739,Whether more subtle anomalies of thyroid hormone metabolism influence the progression of CAD remains a matter of speculation
1418,"Notch, Wnt / β - catenin, bone morphogenic proteins ( Bmp ) and Sonic Hedgehog ( Shh ) pathways"
4439,[CLS]
1631,H3K27ac
3459,[CLS]
2454,[CLS]
1009,[CLS]
712,[CLS]
4501,[CLS]
2719,three - legged pinwheel - shaped heteropolymer
273,an inactivated X chromosome in the normal female somatic cell
448,[CLS]
3329,[CLS]
4569,[CLS]
2845,[CLS]
2807,Otx2
1698,XK
488,[CLS]
605,[CLS]
3901,[CLS]
4625,molecularly - targeted
574,cytoplasmatic mRNP granules
4344,[CLS]
2118,percutaneous coronary intervention ( PCI ) and coronary artery bypass graft ( CABG )
1186,IKKbeta and NEMO
1616,[CLS]
1465,[CLS]
2988,[CLS]
4258,[CLS]
4699,[CLS]
2978,[CLS]
621,[CLS]
3315,[CLS]
665,they do cast doubt on the robustness of the previously reported effects of sirtuins on lifespan in C. elegans and Drosophila.
833,ataxin - 3
2623,[CLS]
938,innate antiviral immunity
0,multifactorial
4583,[CLS]
3738,[CLS]
1125,[CLS]
619,autosomal recessive fashion
250,[CLS]
3246,provides durable occlusion of the annular defect
3888,[CLS]
935,"chronic sinusitis, bronchiectasis, and situs inversus"
4335,hypopharyngeal glands
1392,[CLS]
4563,[CLS]
1113,EGFR kinase domain
1142,[CLS]
406,[CLS]
1126,"KCNH2, KCNQ1, and KCNJ2"
537,[CLS]
4516,[CLS]
3506,Asbestos exposure causes asbestosis and malignant mesothelioma
371,[CLS]
2963,[CLS]
415,Transcribed Alu sequences can alter splicing patterns by generating new exons
2908,[CLS]
4351,insensitivity
3857,IL - 1α and IL - 1β
967,[CLS]
270,[CLS]
434,might stabilize c - myc mRNA in vitro by protecting it from endonucleolytic cleavage
3956,Extracorporeal membrane oxygenation
1327,"necroptosis, apoptosis, and pro - survival / inflammation NF - κB activation"
350,significant growth rate deficit
4674,[CLS]
2640,[CLS]
3314,[CLS]
1868,a degenerative fasciosis without inflammation
1660,[CLS]
725,Deficiency
646,"different animal groups, with different core GRNs, contain alternative sets of CNEs"
510,[CLS]
2616,[CLS]
2531,"fever, uveitis, parotid gland enlargement, and facial nerve palsy"
3843,Xp22. 3
3823,"a public, freely available, integrative translational research and drug discovery knowlegebase"
2178,"recurrent facial palsy, lingua plicata and orofacial edema"
1080,suprapubic ultrasonography
4371,arginine vasopressin
1762,[CLS]
1965,"unspecific, but otherwise typical clinical symptoms"
3145,[CLS]
4343,[CLS]
970,variable - length DNA sequence motifs in the human genomes
242,nucleoprotein complex
3766,[CLS]
1963,origin recognition complex
2685,[CLS]
4268,[CLS]
3270,B - cell activating factor
862,nearly symptomless to a severe disease
3534,dominant
916,[CLS]
1881,[CLS]
1439,autosomal recessive
3391,[CLS]
2207,ubiquitous presence of CPP1 in oxygenic photosynthetic organisms
4308,[CLS]
2679,[CLS]
4641,substrate recognition protein in the E3 - ligase ubiquitin complex
884,[CLS]
13,arrested cell - cycle progression and the development of aberrant gene expression with proinflammatory behavior
312,[CLS]
1052,no clinical benefit
2959,[CLS]
2196,"expression state, chromosomal location, and nuclear position"
3480,[CLS]
3980,[CLS]
2104,ADAMTSL4
893,Sudden death due to low - energy blunt trauma to the precordium
4313,[CLS]
4336,[CLS]
3354,Coronaviridae
132,tens of thousands
2887,[CLS]
2044,protein - losing enteropathy
1171,[CLS]
2834,[CLS]
4423,"Cytoscape plug - in, GPEC"
1903,[CLS]
4263,[CLS]
2478,[CLS]
3323,[CLS]
1860,[CLS]
4412,[CLS]
2981,[CLS]
4466,[CLS]
1586,direct in vitro transposition of sequencing adaptors into native chromatin
1209,[CLS]
4092,[UNK] %
1870,[CLS]
2378,[CLS]
1853,[CLS]
1307,[CLS]
3960,[CLS]
2517,[CLS]
2656,[CLS]
2225,Nrd1 - exosome - TRAMP complexes
46,"Internet - based interventions using cognitive behavioral approaches can be effective in promoting self - management of chronic pain conditions. Web - based programs delivered via smartphones are increasingly used to support the self - management of various health disorders, but research on smartphone interventions for persons with chronic pain is limited"
3691,"[CLS] Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects? [SEP] Much research has gone into developing medications that can be used to alleviate endometriosis - associated symptoms. In addition to already established medications, a new GnRH antagonist, elagolix"
3568,[CLS]
4605,[CLS]
258,[CLS]
3012,limited
4274,[CLS]
1039,[CLS]
3644,a flow management framework
1212,[CLS]
4693,EGFR / MAPK
3439,320 - kb
4185,relieve
1659,"S2246L, N4104K, and R4497C"
3471,act as epigenetic suppressors
447,[CLS]
4037,acts as an interleukin - 6 receptor antagonist
3850,[CLS]
1776,CD38
3599,[CLS]
1393,genome instability and cancer
4698,[CLS]
785,[CLS]
1671,[CLS]
457,IL - 5
3861,Anakinra
4448,[CLS]
2252,optimal ribosome stabilization
2772,[CLS]
4044,[CLS]
600,[CLS]
592,[CLS]
3416,[CLS]
1033,mutant accumulation in populations that are repeatedly subjected to genetic bottleneck
2544,[CLS]
2710,[CLS]
1492,[CLS]
3282,[CLS]
1323,[CLS]
2286,it does not affect voice performance in long term after surgery
1141,[CLS]
1541,[CLS]
2948,[CLS]
4505,[CLS]
3689,sphingosine - 1 - phosphate
1684,[CLS]
261,[CLS]
3655,failed to produce any significant treatment benefits
1909,nerve growth factor
3357,the interaction between SARS - CoV and the immunological or lymphoid system
3366,[CLS]
3276,MYH7
4549,Progranulin
1635,temperature - dependent change in the stability of its mRNA
4354,[CLS]
3048,[CLS]
3176,microtubules
3813,[CLS]
3672,[CLS]
3865,[CLS]
145,[CLS]
4228,interferon
1639,drugs that modify an acidic environment
3815,[CLS]
506,conserved
3359,FIPVs having a mutated 3c
4230,[CLS]
1577,[CLS]
4137,[CLS]
4489,[CLS]
875,Sushi. R
239,"Hedgehog, ( Hh ) Notch, and Wnt"
362,[CLS]
3101,[CLS]
3537,[CLS]
1839,congenital birth defects and the Guillain - Barré syndrome
4422,[CLS]
659,diffuse myocardial fibrosis
1750,[CLS]
2323,[CLS]
1388,[CLS]
1437,selective 2 ' - hydroxyl acylation analyzed by primer extension sequencing
3936,[CLS]
1764,chronic neuropathic pain
2603,assignment of identified peptides to the proteins from which they originate
4194,[CLS]
2142,a common form of human dwarfism
1135,[CLS]
3079,[CLS]
937,[CLS]
2561,[CLS]
116,loss of function of the survival motor neuron gene
208,DePCRM
3197,[CLS]
2858,[CLS]
3440,secondary prevention studies
3095,11p11. 2p12
140,heterochromatin protein 1 and polycomb protein
4182,[CLS]
3289,[CLS]
4691,[CLS]
2645,controls diverse biological processes by covalently conjugating the ubiquitin - like protein NEDD8 to specific targets
868,Bulbar ( 87 % ) and autonomic ( 95 % ) symptoms
3648,Ghent criteria
2914,[CLS]
1857,transport of thyroxine from the blood to the brain
3465,[CLS]
4341,[CLS]
1359,[CLS]
4668,[CLS]
1830,"enterovirus, herpes simplex virus ( HSV ), and varicella zoster virus ( VZV )"
234,"cancer diagnosis, imaging, and therapy"
2635,[CLS]
1241,[CLS]
1700,mTOR
1871,[CLS]
4594,synthetic cannabinoid
2296,[CLS]
524,rapid recycling back to the plasma membrane
2666,[CLS]
1782,one of the principle non - splice site motifs
654,[CLS]
2577,severely injured
707,[CLS]
1886,MITF
219,[CLS]
1535,[CLS]
2932,[CLS]
1968,Reduced fertility
1769,Teriflunomide
1557,[CLS]
726,[CLS]
3252,[CLS]
3060,[CLS]
2835,[CLS]
1180,a database of pseudogene families
3460,rare
1902,[CLS]
2460,[CLS]
562,valproic acid
1020,[CLS]
1379,[CLS]
555,[CLS]
1617,quiescent mononucleated myogenic cells
4544,[CLS]
4514,ACEIs and ARBs do not promote a more severe outcome of COVID - 19
190,platelet - derived growth factor receptor - α
2747,FunImageJ
2483,over / ectopically expressed by tumors
858,[CLS]
3558,[CLS] Describe the mechanism of action of a drug Elagolix. [SEP] ovarian hormone concentrations
2264,[CLS]
2012,conventional en masse repair and separate double - layer double - row repair
4375,[CLS]
1446,The association of AVS and gastrointestinal bleeding from angiodysplasia
1290,"age, syncope, family history of sudden cardiac death, cardiac arrest survivor, nonsustained ventricular tachycardia and abnormal blood pressure response to exercise"
2035,[CLS]
225,[CLS]
618,weight loss
4006,[CLS]
2,[CLS]
4123,[CLS]
4370,[CLS]
2683,severe cell growth inhibition
2191,transcription
4574,fish
3326,[CLS]
3969,[CLS]
2182,[CLS]
2545,[CLS]
3275,[CLS]
495,SPINK5
233,Sypro Ruby
2840,[CLS]
2824,α - Synuclein
2484,Cseq - Simulator
177,[CLS]
2898,[CLS]
2592,sex differences
996,[CLS]
4235,[CLS]
2493,[CLS]
1066,[CLS]
3215,moesin
3068,[CLS]
2355,[CLS] What is the Strelka workflow? [SEP] Single - cell analysis
2848,[CLS]
684,[CLS]
4565,[CLS]
3600,G380R
522,acute myeloid leukemia and squamous cell carcinomas
2052,ChIA - PET
2267,[CLS]
2913,[CLS]
3085,[CLS]
3699,[CLS]
3089,[CLS]
468,[CLS]
3512,[CLS]
2718,[CLS]
965,fundamental structural and functional building blocks of human interphase chromosomes
2112,"microtubules, intermediate filaments and microfilaments"
4147,speckled black pigmentation of the duodenal mucosa
2293,Circularized oligonucleotides
3273,[CLS]
4710,intact esophageal peristaltic contractions with extremely elevated amplitudes
1037,"It is not associated with an increased risk of gestational diabetes, impaired fetal growth or altered neonatal cord plasma insulin secretory profile."
4005,"baricitinib, decernotinib, filgotinib and INCB - 039110"
125,Perineural
1326,[CLS]
1926,long noncoding RNAs
4107,Janus kinase 1
4275,spinal muscular atrophy
1431,Friedreich ' s ataxia ( FRDA ) and Huntington ' s disease ( HD )
1674,"can be used in conjunction with any multiple sequence alignment program, to address this problem effectively and efficiently"
1599,[CLS]
3808,[CLS]
548,[CLS]
1306,a competition on large - scale biomedical semantic indexing and question answering ( QA )
2713,coagulation factor Xa
2568,they participate in cancer - related pathways
3130,there are no effective methods to alter the disease course in Alzheimer ' s disease.
2615,visceral leishmaniasis
4345,[CLS]
793,[CLS]
3626,King - Kopetzky syndrome
1547,APOBEC3G ( A3G ) and APOBEC3F ( A3F )
1525,1100delC
3253,membrane protrusions that localize enzymes required for ECM degradation
3566,[CLS]
2084,male external genitalia
295,"delayed bone age, cone shaped epiphyses, thick skin and heart disease"
3022,CYP3A
153,[CLS]
1991,"cytokines, stress proteins, adhesion molecules, and autoantigens"
1980,[CLS]
4388,[CLS]
4007,[CLS]
1757,stimulated mitochondrial recruitment of Drp1 accompanied by mitochondrial fission
4072,[CLS]
3592,interleukin - 6
4353,[CLS]
1809,HTT
927,[CLS]
1687,CRISPR interference
1932,[CLS]
2918,cellular adhesion
2618,[CLS]
4682,[CLS]
4463,[CLS]
3404,[CLS]
1915,[CLS]
2975,Its effectiveness in reducing oral glucocorticoid use in patients with severe asthma while maintaining asthma control is unknown
37,"acquired hemolytic anemia, thrombocytopenia and renal failure"
2546,erectile dysfunction
891,[CLS]
2741,[CLS]
4383,[CLS]
1538,[CLS]
222,[CLS]
1433,Bapineuzumab
2724,melanoma
3446,huntingtin
3291,[CLS]
611,Cardiovascular disease
3464,heterotopic endochondral ossification
3949,[CLS]
888,during DNA replication per cell - division
4478,[CLS]
591,[CLS]
2530,[CLS]
1510,[CLS]
1081,[CLS]
3870,[CLS]
2498,[CLS]
2815,[CLS]
14,castration - resistant prostate cancer
2136,no genes associated with these disorders have been identified
3411,Ileal pouch - anal anastomosis
825,suspected to cause a substantial part of sudden cardiac deaths in young individuals
1255,[CLS]
4715,[CLS]
3436,[CLS]
120,[CLS]
3635,[CLS]
3355,an aggressive immune response characterized by the recruitment of inflammatory leukocytes and exaggerated levels of cytokines and chemokines at the site of infection
565,dysregulation
369,female
2233,DNA replication initiation and cell proliferation of eukaryotic cells
1297,unclear
2773,BioCreative Meta Services
3970,[CLS]
1387,entity mention normalization
3509,[CLS]
860,"Fanconi cells are highly sensitive to DNA crosslinking agents, their response to ionizing radiation is still unclear"
2851,[CLS]
2698,[CLS]
1920,compartment syndrome of the forearm
2481,[CLS]
1542,the role of thyroid hormones in congestive heart failure has not been well defined
3186,Bapineuzumab
2764,magnetic resonance imaging
440,"meconium peritonitis, cystic fibrosis, aneuploidy, congenital viral infection and intrauterine growth restriction"
179,cholesterol and sphingolipids rich subcellular domains on plasma membrane
1144,HD
2064,[CLS]
378,brain iron
2480,"World Health Organization ( WHO ), Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults - Adult Treatment Panel III ( NCEP - ATP III ), and International Diabetes Federation ( IDF )"
3714,[CLS]
3877,[CLS]
3430,[CLS]
428,[CLS]
374,[CLS]
857,a malformation of the cervicomedullary junction
1925,[CLS]
2209,evolocumab and alirocumab
431,poor prognosis
984,[CLS]
2238,[CLS]
4121,[CLS]
4083,KRAS p. G12C
1199,microcephalic osteodysplastic primordial dwarfism
4702,a naturally occurring flavone
1303,[CLS]
1055,splicing is often cotranscriptional
3096,[CLS]
4440,[CLS]
1836,[CLS]
3235,signals in cell density - dependent gene regulation
1912,[CLS]
423,autosomal dominant type
4184,"[CLS] Are interferons defensive proteins? [SEP] of the innate immune system, humans encode proteins that inhibit viruses such as HIV - 1. These broadly acting antiviral proteins do not protect humans from viral infections because viruses encode proteins that antagonize the host antiviral proteins to evade the innate immune system"
436,Clinical trials have shown that short - and long - term progesterone treatment induces a significant improvement in the level of disability among patients with brain injury
1908,congenital Horner syndrome
4157,[CLS]
2422,CancerSubtypes
3157,[CLS]
3891,[CLS]
2006,"hypoalbuminemia, hypocalcemia, lymphopenia and hypogammaglobulinemia"
811,[CLS]
1007,enzymatically inserting G - to - A mutations in viral DNA and / or impairing viral reverse transcription independently of their deaminase activity
678,[CLS]
4239,[CLS]
2443,[CLS]
4168,far from
1065,[CLS]
22,"both processes are coordinated and, in some cases, functionally coupled"
2759,several hundred
2033,olanzapine and risperidone
1835,The mechanism by which statins cause diabetes has not been elucidated
2036,not clear
3492,[CLS]
3138,[CLS]
4133,"refractory seizures, disability, and early death"
1140,[CLS]
1181,Mixed Integer Transcript IdEntification
3020,[CLS]
3031,not similarly effective in all patients
615,[CLS]
1133,[CLS]
799,[CLS]
2168,[CLS]
657,[CLS]
3726,platelet - derived growth factor receptor - α
989,[CLS]
3405,a variety of systemic diseases
2465,"[CLS] What is the mechanism of action of Fremanezumab? [SEP] PURPOSE OF REVIEW : Sotatercept and luspatercept are recombinant soluble activin type - II receptor - IgG - Fc fusion proteins that are tested in clinical trials for the treatment of various types of anemias, including renal anemia. The mechanism of the action of the novel drugs is incompletely understood, but it seems to be based on the inactivation of soluble proteins of the transforming growth factor - ß ( TGFß ) family"
2090,severe homocystinuria as a multisystem disorder
872,[CLS]
2505,[CLS]
1949,methylKit
2282,the efficacy of the treatment remains controversial
314,[CLS]
1658,[CLS]
2203,"alacrima, achalasia, and adrenal failure"
2366,[CLS]
4202,[CLS]
3021,[CLS]
4690,ANCA - associated vasculitis
288,"to produce transgenic animals, cell lines, and plants, and to treat human disease"
1105,[CLS]
4035,RAS
2081,[CLS]
719,[CLS]
3546,[CLS]
4593,[CLS]
4380,[CLS]
4515,10058 - F4
183,those that regulate innate and adaptive immunity
3758,[CLS]
534,[CLS]
4522,[CLS]
1628,serotonin 2A
3745,[CLS]
160,[CLS]
2912,[CLS]
2302,DCC and CircTest
3467,[CLS]
3769,behavioral regression and bowel symptoms
1827,[CLS]
722,TMBETA - GENOME
1278,[CLS]
1462,melanoma or angiosarcoma
2494,[CLS]
1096,Na ( + ) and RyR2 channels
3864,[CLS]
788,"mutation in genes encoding proteins required for the Fanconi anemia pathway, a response mechanism to replicative stress"
4126,five belonged to the family of major royal jelly proteins 1 - 5
2059,[CLS]
2474,[CLS]
4118,[CLS]
3377,[CLS]
3152,[CLS]
1260,[CLS]
33,Terminal Amine Isotopic Labeling of Substrates
783,regulate gene expression
410,[CLS]
3716,Vaxchora
4181,CYP2C9 and VKORC1
4080,[CLS]
982,pericentromeric
2468,Ancora
3798,[CLS]
3771,[CLS]
2746,regions surrounding transcriptional start sites and within long terminal repeat elements
4703,[CLS]
3203,endocrine status
4111,[CLS]
1863,sudden onset of hemifacial sweating and flushing
1648,[CLS]
3200,Luxturna
3469,"a chronic, low - grade - inflammatory disorder"
1369,through translational repression of their target genes
1100,[CLS]
3645,Cytoscape
1854,first - line antidepressant option
950,tolcapone and entacapone
3013,June 2017
2929,3D physiological in vitro structures
1479,regulates gene expression
101,[CLS]
2262,[CLS]
1243,[CLS]
3257,double vision and oscillopsia
4010,hepatocyte nuclear factor 4 alpha
3034,[CLS]
2780,"its therapeutic effect has been tested in patients with an acute exacerbation of schizophrenia and in patients with acute mania in bipolar disorder. Like risperidone, cariprazine improves positive and negative schizophrenic symptoms, and ameliorates cognitive functions. Cariprazine induces extrapyramidal symptoms less often than risperidone and can cause acute akathisia. It is a prolactin - sparing antipsychotic drug and has a favorable metabolic profile. In acute mania in bipolar disorder, it treats manic symptoms significantly better than placebo. As a consequence of its improved adverse effects, cariprazine improves patients ' quality of life to a greater extent than other second - generation antipsychotic drugs. Cariprazine is a promising antipsychotic drug in the treatment of schizophrenia, acute mania in bipolar disorder, and in schizophrenia with mania. In these patients, its long - term therapeutic effect and its action in comparison with other second - generation antipsychotic drugs, above all aripiprazole, remain to be tested in clinical trials"
1484,Intravenous clonidine 1 microg / kg
3930,[CLS]
1686,[CLS]
3350,an aggressive immune response characterized by the recruitment of inflammatory leukocytes and exaggerated levels of cytokines and chemokines at the site of infection
2849,[CLS]
1994,H3F3A p. K27M or p. G34
3269,rare cancer predisposition syndrome inherited in an autosomal dominant fashion
3975,[CLS]
1367,[CLS]
4447,"malaria, cancer, fibrosis and inflammatory disease"
882,"Nivolumab is the first PD - 1 inhibitor approved for the treatment of advanced - stage squamous cell non - small - cell lung cancer following platinum - based chemotherapy. In the key Phase III trial CHECKMATE 017, a better overall survival and progression - free survival were seen in patients treated with second - line nivolumab compared with docetaxel. Programmed death ligand - 1 ( PD - L1 ) expression did not predict for outcome. In addition, nivolumab had better safety and tolerability, and led to better patient reported outcomes. Further research on the role of PD - L1 expression as a predictive biomarker should be performed, and other biomarkers that can predict the efficacy of PD - 1 / PD - L1 inhibitors should also be pursued. Further studies on the combination treatment are ongoing to determine the optimal role of nivolumab as monotherapy"
196,[CLS]
4131,[CLS]
4261,[CLS]
4058,[CLS]
2257,neurons and glia
1701,"None of the three SNPs in the voltage - gated potassium channel gene, KCNQ2, was associated with IGE"
2488,[CLS]
1159,[CLS]
4290,[CLS]
4091,acute oral treatment for migraine
3468,they should both recapitulate the molecular heterogeneity of PDAC and validate patient - specific therapeutic sensitivities
114,multiple
703,[CLS]
2374,Corynebacterium minutissimum
59,telomerase
1411,[CLS]
4717,[CLS]
3445,a high incidence of tumors of the nervous system
3418,ClC - Kb
737,SERCA2a
4464,piwi - interacting RNAs
1770,stimulate specifically the erythropoietin receptor dimer that governs erythropoiesis
4106,signatureSearch
1632,[CLS]
1169,by down - regulating genes that are important for drug function
3733,failed to meet its primary endpoint of improvement in 4 month progression - free survival as a single agent in previously treated metastatic colorectal cancer patients
4474,[CLS]
1518,[CLS]
1741,[CLS]
4679,[CLS]
3148,[CLS]
602,"LC3, GABARAP, and GATE - 16"
2721,The mechanism of virulence of Brucella spp. is not fully understood
4414,[CLS]
2518,[CLS] Clue cells are characteristics to which causative bacteria of vaginitis? [SEP] group B streptococci and E. coli
7,pyridostigmine
1506,Global DNA hypomethylation
1406,largely limited to CODIS data and the ability to match samples and assign them to an individual
1390,[CLS]
3030,its long - term efficacy is still arguable
1315,225 to 240 ms
17,to map the human proteome
438,natriuretic peptides
4152,There are numerous examples of sex differences in brain and behavior and in susceptibility to a broad range of brain diseases
4358,[CLS]
1523,[CLS]
1167,[CLS]
4304,[CLS]
2153,"episodes of palpitations, headaches, and profuse sweating"
1761,[CLS]
2649,neuroblastoma
4300,[CLS]
4160,small leucine - rich repeat
364,[CLS]
1825,[CLS]
686,[CLS]
2134,[CLS]
4040,there is no consensus for the best practice of scATAC - seq data analysis yet
1931,guanosine - 5 ' - triphosphate - binding proteins
3260,[CLS]
1536,higher affinity bilirubin uptake transporter
3809,[CLS]
2919,[CLS]
4584,chromosomal genome sequence
3171,[CLS]
3702,[CLS]
576,[CLS]
3651,vacuole
3562,OncoPPi Portal
63,Conservation of gene sequences
547,reactions to ingestion of nickel rich foods in patients with nickel allergic contact dermatitis
2117,It occurs more frequently in males
1405,[CLS]
3712,[CLS]
2769,[CLS]
3657,[CLS]
997,O ( n2log n )
1107,"IKK - α, - β and - γ"
4052,[CLS]
2619,[CLS]
290,fibroblast growth factor receptor 3
3010,[CLS]
895,directly
1972,regulating gene expression
2816,paralogous gene pairs generated by whole genome duplication
3906,[CLS]
2916,[CLS]
2402,[CLS]
2984,[CLS]
1884,[CLS]
1351,Medicarpin
2532,[CLS]
582,[CLS]
1529,"Single - cell gel electrophoresis, or the comet assay"
2559,[CLS]
1641,beta - N - acetylhexosaminidase A
4096,Slit
155,[CLS]
2091,[CLS]
2273,48
4390,[CLS]
807,increased
4638,[CLS]
1797,binding covalently to cell proteins or DNA
3653,Multiply inverted
1982,[CLS]
1627,[CLS]
3845,[CLS]
391,[CLS]
4025,[CLS]
1190,viruses
2771,[CLS]
596,[CLS]
1704,contiguous regions of gene suppression
2598,[CLS]
536,neutrophil elastase
3312,[CLS]
4451,[CLS]
408,variable - length DNA sequence motifs
757,phycoerythrin
864,decreased
3838,[CLS]
2676,at the nucleotide level within LCRs
4249,[CLS]
4379,[CLS]
3414,[CLS]
4057,CYP2D6
4120,poorly characterized
135,[CLS]
3009,MCScan
331,Sushi. R
968,[CLS]
1089,prominent myocardial trabeculations and deep inter - trabecular recesses that communicate with the ventricular cavity
1455,unclear
4213,the efficacy of the treatment remains controversial
2103,[CLS]
4519,p300
115,"Brooke - Spiegler syndrome, ( Familial ) Cylindromatosis or multiple familial trichoepithelioma"
1582,[CLS]
2520,de Quervain ' s disease
1333,not have additional beneficial effects
2524,"respect for autonomy, nonmaleficence, beneficence and justice"
5,[CLS]
3309,[CLS]
1957,[CLS]
680,[CLS]
2347,[CLS]
4075,[CLS]
4286,catalyze the attachment of glycans to specific amino acid residues in target proteins
171,[CLS]
2680,an intra - epidermal adenocarcinoma
3444,[CLS]
941,relative contribution of selenoproteins and small Se compounds in cancer protection is still a matter of debate
3311,CVD 103 - HgR
2022,an amino acid sequence that encodes a protein degradation signal
1403,sub - cellular
1501,[CLS]
1253,to analyse the actual survival time of patients treated for metastatic spinal cord compression ( MSCC ) in comparison with the predicted survival
641,[CLS]
102,thionamides and glucocorticoids
4098,[CLS]
23,autosomal dominant
3544,[CLS]
1737,without protecting tumor tissues
4329,malignancies
3601,[CLS]
1498,a mixture of five SILAC - labeled cell lines
4599,[CLS]
1104,Atrial fibrillation
2700,regulation of transcription
2440,[CLS]
210,HAX - 1
4166,d - lactate and l - lactate
3221,adipocyte - specific secretory hormone
560,[CLS]
3507,[CLS]
711,[CLS]
4395,[CLS]
1996,[CLS]
2386,[CLS]
401,Ser - 129
1352,inversely correlated with disease - specific survival
1050,personalized diagnostic and therapeutic approaches
3942,[CLS]
914,autoimmune
715,[CLS]
463,negatively
1208,lineage - specific rate variation
2901,a defect in the transport of cystine across the lysosomal membrane
1961,RADAR
2121,[CLS]
1562,[CLS]
2408,[CLS]
2235,[CLS]
3658,[CLS]
4125,well tolerated
4458,[CLS]
1916,[CLS]
4359,[CLS]
1269,[CLS]
594,[CLS]
407,[CLS]
2219,back - spliced reads
3794,[CLS]
4352,[CLS]
2791,[CLS]
2573,Boolean analysis
3419,[CLS]
903,[CLS]
1569,[CLS]
4031,[CLS]
3109,actoxumab and bezlotoxumab
1579,[CLS]
2540,"transient haemolytic anaemia, jaundice, hyperlipoproteinaemia, and alcohol - induced liver disease"
2190,[CLS]
3345,[CLS]
2268,[CLS]
1115,[CLS]
813,The frequency of the favored allele increases in the population
4694,[CLS]
2539,[CLS]
4154,[CLS]
3742,SD
2354,promotes bone formation
90,activated fibroblast - like synoviocytes
3263,[CLS]
2406,[CLS]
296,[CLS]
3530,Helicobacter pylori
3427,[CLS]
2628,[CLS]
2744,[CLS]
3488,direct antitumor effect
3387,[CLS]
4577,[CLS]
1123,Global run - on sequencing
3362,[CLS]
2083,mutations in the SLC26A4 gene
1277,[CLS]
283,[CLS]
2800,[CLS]
2613,Salmonella Typhi
1028,LXXLL motifs
1451,[CLS]
3307,trifluridine and tipiracil
4401,[CLS]
297,Cyclophilins are ubiquitously expressed proteins
3191,[CLS]
139,centromeres
4601,The most frequent clinical complication
4662,[CLS]
2106,[CLS]
3863,dose - dependent reduction of weight
2438,IL ) - 12 and IL - 23
787,[CLS]
2569,whole - exome sequencing
3880,[CLS]
3583,[CLS]
1059,transposon silencing
709,[CLS]
2995,osteoporosis of hyperprolactinemia is likely due to PRL - induced hypogonadism
3841,Hemochromatosis
292,rearranged during transfection gene
306,[CLS]
4571,[CLS]
2830,ezTag
3659,[CLS]
2301,[CLS]
2279,[CLS]
3555,[CLS]
2265,[CLS]
2021,[CLS]
2611,Asia
760,X linked
2833,[CLS]
3885,Chromatin Isolation by RNA Purification
3939,"dysplasia of all of the bony components of the elbow joint, abnormalities in the shape of carpal bones, and brachydactyly"
180,genome activity and stability
2253,[CLS]
2375,SMARCAL1
2007,[CLS]
1091,inactive X chromosome
499,[CLS]
4400,The protein moiety of royal jelly comprises mostly major royal jelly proteins
2723,fibrous cords under the skin of the palm of the hand
1748,heterochromia iridis and cochlear deafness
1349,[CLS]
550,[CLS]
4678,[CLS]
2879,[CLS]
478,[CLS]
21,autosomal recessive
4434,not repress the SATB1 - regulated genes
2821,DeepVariant
1862,excitatory synapses
3505,[CLS]
4254,[CLS]
942,drug validation
3489,[CLS]
345,"CircRNAs are conserved across different species and display specific organization, sequence, and expression in disease"
3990,3D physiological in vitro structures
3352,[CLS]
1933,a severe form of intractable pediatric epilepsy
3997,"Alobar, Semilobar, Lobar and Middle interhemispheric fusion variant"
3483,[CLS]
1759,an inherited prion disease
3328,[CLS]
2348,SMAD4 and BMPR1A
2108,[CLS]
4456,[CLS]
2551,[CLS]
500,repressor
1718,three
3705,[CLS]
1274,The clinical manifestations of FA are heterogeneous
4450,[CLS]
106,ReactomeGSA
566,[CLS]
256,disrupts the activity of the mycobacterial adenosine triphosphate synthase
4164,[CLS]
3058,[CLS]
298,[CLS]
3268,[CLS]
214,[CLS]
4001,first drug to reach clinical trials
3407,prominent small vessels
405,"matrilin 1 ( MATN1 ), melatonin receptor 1B ( MTNR1B ), tryptophan hydroxylase 1 ( TPH1 ), and insulin - like growth factor 1 ( IGF1 )"
2078,[CLS]
1207,[CLS]
3663,[CLS]
3443,[CLS]
2062,[CLS]
936,[CLS]
3184,"there are no effective methods to alter the disease course in Alzheimer ' s disease. All FDA approved interventions are for symptomatic relief only. However, it is an exciting time as many agents in development have theorhetical potential to impact the disease course. This review discusses some of the agents that have been in clinical trials, particularly those that affect amyloid processing. Some agents have failed while others still provide hope"
821,[CLS]
2199,[CLS]
3011,Clostridium difficile
4427,[CLS]
4207,[CLS]
4342,"March 26, 2021"
3181,"gastrointestinal complaints, inflammation, and rheumatic disorders"
2881,one of the most abundant in many of the living organisms
769,[CLS]
3953,[CLS]
2826,[CLS]
2507,[CLS]
3792,[CLS]
4373,[CLS]
1193,[CLS]
1811,SLC9A6
3251,"anorectal stenosis, a defect in the sacral bone, and a presacral mass"
3928,[CLS]
3369,[CLS]
3342,[CLS]
840,"Sonic Hh, Indian Hh, and Desert Hh"
122,Enteroviruses
2703,[CLS]
2823,[CLS]
774,eRNAs and H3K27ac
1485,[CLS]
2111,[CLS]
1245,normal horse tears
1859,neural crest
2315,unclear
734,[CLS]
